Navigation Links
Genegnome Bio Imaging System for Chemiluminescence

ProductsGenegnome Bio Imaging System for Chemiluminescence
Company Syngene
Item Genegnome Bio Imaging System for Chemiluminescence
Features Increased productivity: Genegnome is equipped with a powerful built-in computer and combines our award-winning software with the simplest to use hardware on the market. This combination ensures that Genegnome can be used with speed and accuracy by everyone in the laboratory. Easy image acquisition: this is simplicity itself - all you have to do is to place a blot into the sample tray, press in and click one button. Genegnome will immediately acquire an image and display this on the flat screen monitor. Automatic analysis: The unique Genetools software will produce a complete analysis solution in under 8 seconds. Unique accuracy: Genegnome has some of the most powerful algorithms ever developed for gel analysis. The intelligence built into the system reduces the scope for error and is further enhanced by its compliance with good laboratory practice. Image handling: Genegnome has a simple to use image acquisition interface. Fully automatic and more sensitive than film.
Description Genegnome is a dedicated high performance bio imaging system for chemiluminescence applications. Genegnome completely automates the process of imaging chemiluminescent samples. It provides superbly accurate results and is extremely easy to use, unique image analysis algorithms and powerful imaging hardware.
Info Syngene
Customer Service: (800) 686-4407
Web site: http://www.syngene.com

Related medicine products :

1. Genegnome HR
2. KOWA nonmyd 7 / VK-2 Digital Imaging System
3. KOWA nonmyd a-D / VK-2 Digital Imaging System
4. Spinal Imaging Platform
5. Sononav Intraoperative Imaging System
6. VISERA Imaging System
7. Stealthstation Siemens Siremobil Iso-C3D C-Arm Imaging System Interface
8. Atlantis SR Pro Coronary Imaging Catheter
9. Galaxy Digital Imaging Console
10. Statscan Critical Imaging System
11. Khosla Slit Lamp Imaging System
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products:
(Date:3/2/2015)... Monroeville, PA (PRWEB) March 02, 2015 ... part of the Allegheny Health Network, are ... with new software called Visual Info Zonal Reminder (VIZR), ... , Introduced in 2013, Google Glass is a wearable ... in a smartphone-like hands-free format. Wearers communicate with the ...
(Date:3/2/2015)... CA (PRWEB) March 02, 2015 Ticket ... tickets at the Hollywood Bowl . This popular site ... customer appreciation promo code JIMMY-BUFFETT-2015 for added savings. , ... their favorite performer will be headlining at the Hollywood ... concert will be on Thursday, October 22nd and it ...
(Date:3/2/2015)... 02, 2015 Doctors in Novara, Italy ... better predictor of outcomes for people with mesothelioma than ... of the new study on the Surviving Mesothelioma ... University of Eastern Piedmont followed the cases of 172 ... for excess lung fluid. , “Persistent lung expansion ...
(Date:3/2/2015)... 02, 2015 Burns Engineering's Lab-to-Lab ... for Secondary Standard Platinum Resistance Thermometers (SSPRTs) and ... days or less . . . guaranteed. ... Accredited (Lab Code 200706-0), ISO 9001 and 17025 ... range is -196°C to 500°C, both ITS-90 and ...
(Date:3/2/2015)... The minimally invasive surgical instruments market ... 6.1% to reach $14,133.0 million by 2019 from ... as advantages of minimally invasive surgeries over traditional ... invasive surgeries and increasing number of surgical procedures ... minimally invasive surgical instruments market. , For More ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2
... University may have isolated the substance most responsible// for ... a discovery that could revolututionise treatments for a host ... by Riyi Shi (REE-yee SHEE) has found that a ... high levels in spinal tissue for several days after ...
... who are being diagnosed for diabetes type 2 may ... the onset of the disease. ,A study done ... have shown that among the children who are newly ... five of them have showed tendencies of being afflicted ...
... to find out why the diabetes drug thiazolidinediones (TZDs) can ... found that the drug TZDs activates a receptor in kidney ... the collecting duct of the kidney. The activation of the ... causes edema. ,TZD drugs are generally used to lower ...
... the help of anti fungal medication itraconazole can reduce ... have broken new grounds in asthma treatment by using ... aspergillosis, which is a form of asthma. , ... with steroids or drugs that have equally disastrous side ...
... is trying new approaches to the neuroblastoma patients, researchers// ... more effective in children than the common procedure. ... that the cancer drug topotecancan must be fine tuned ... all doses are effective on everybody. Only less than ...
... placebo treatment can reduce the nature of emotional experience// ... treatment consists of dummy medication or intervention. This can ... injections etc. ,In the new research done by ... placebo treatment can effectively control the impact of negative ...
Cached Medicine News:Health News:Acrolein may be the key to halting spinal cord damage 2Health News:Acrolein may be the key to halting spinal cord damage 3Health News:Acrolein may be the key to halting spinal cord damage 4
(Date:3/2/2015)... , March 2, 2015 Nevro Corp. (NYSE: ... has developed and commercialized an innovative, evidence-based neuromodulation platform ... Brad Vale , PhD, DVM, former Head of ... to its Board of Directors, effective March 1, 2015. ... of experience in developing, commercializing and investing in innovative ...
(Date:3/2/2015)... WEST JORDAN, Utah , March 2, 2015 ... of Medical Imaging Solutions, has acquired Eclipse Systems, ... and customized service solutions. As part of their ... comprehensive service at an affordable rate, BC Technical ... strategic acquisition allows BC Technical to add valuable ...
(Date:3/2/2015)... 2, 2015  DURECT Corporation (Nasdaq: ... and the successful completion of a Phase 1 ... DUR-928.  DUR-928 is an endogenous, small-molecule, new chemical ... metabolic diseases such as nonalcoholic fatty liver disease ... organ injuries such as acute kidney injury (AKI).  ...
Breaking Medicine Technology:Nevro Appoints Dr. Brad Vale to its Board of Directors 2BC Technical Acquires Eclipse Systems 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5